Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
Whales with a lot of money to spend have taken a noticeably bearish stance on Hims & Hers Health. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened ...
Learn more about whether Hims & Hers Health, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...
Learn more about whether Alignment Healthcare, Inc. or Hims & Hers Health, Inc. is a better investment based on AAII's A+ ...
First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...
Hims reveals that while swiping left and right have become synonymous with dating culture among younger generations, the vast ...
Steward Partners Investment Advisory LLC acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional ...
While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...
Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San ...
What's the Most Popular Love Language in America? Hims asked Americans which of the following best describes their love ...
Maintaining their stance, an analyst from Leerink Partners continues to hold a Market Perform rating for Hims & Hers Health, targeting a price of $40. * An analyst from B of A Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results